These results strongly suggest that CD8+ T cells play a key role in the protective immunity induced by the immunization with non-replicable MC38 CRC cells plus rGRA6Nt adjuvant to inhibit the growth of implanted MC38 tumors. Here, CD8A is linked to colorectal carcinoma.